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The early immune events in response to infective larvae of the parasitic helminth Schistosoma mansoni are
poorly understood, but here for the first time we report on the potential of products released by schistosome
larvae (material released in the first 3 h after transformation [0-3hRP]) to stimulate the maturation of
dendritic cells (DC) and alter their T-cell-polarizing function. This was performed in comparison with
lipopolysaccharide (LPS) and zymosan A, which classically activate DC to prime for Th1- and Th2-type
responses, respectively. In our study, immature bone marrow-derived DC stimulated in vitro with 0-3hRP
exhibited up-regulated expression of major histocompatibility complex class II, CD40, and CD86 and increased
production of interleukin 12p40 (IL-12p40) and IL-6, albeit at lower levels than in response to LPS or zymosan
A. Using an in vitro ovalbumin peptide-restricted priming assay, DC matured with 0-3hRP exhibited a potent
capacity to drive Th2 polarization of CD4 cells from DO11.10 transgenic mice. This was characterized by
increased IL-4 production (but not gamma interferon) of a magnitude similar to that primed by DC matured
with zymosan A. Inoculation of DO11.10 mice with 0-3hRP-activated DC pulsed with ovalbumin peptide also
led to the development of a Th2-type polarized response in the skin-draining lymph nodes and spleen. However,
ligation of CD40 on DC by anti-CD40 antibody treatment reversed the ability of 0-3hRP-activated DC to prime
for Th2-type responses and instead caused the induction of a more Th1-type response.
Dendritic cells (DC) are involved in the initiation of both
innate and acquired immune responses and reside in an im-
mature state in peripheral sites, such as the skin and lungs,
where they are optimally located to act as sentinels against
potential pathogens (3). Studies of both human and murine
DC demonstrate that they become activated and mature upon
contact with a variety of different microbe-derived stimuli,
including lipopolysaccharide (LPS) (34), zymosan A (10), and
unmethylated CpG DNA (32). The process of DC maturation
is conventionally associated with up-regulation of major histo-
compatibility complex (MHC) class II and costimulatory mol-
ecule surface expression (10, 32, 34), but it also depends upon
the type of microbial stimulus and can result in the differenti-
ation of DC to distinct phenotypic states (9, 6, 19, 24, 30, 34).
The maturation response is so specific that DC can even dis-
criminate between different cellular states of the same patho-
gen (9). Associated with this differential maturation is the
acquisition by DC of the capacity to prime polarized T helper
(Th) cell responses. Thus, depending upon the initial matura-
tion signal, DC can prime Th cells to differentiate toward the
Th1, Th2, or T-regulatory pole (4, 9, 6, 19, 23, 24, 30, 34).
Although some of the factors that promote Th1 development
(e.g., polarizing cytokines) are well defined, those that promote
Th2 responses are less well understood. Feedback from Th
cells also plays an important role in the phenotypic state of DC
and is likely to be critical in determining the characteristics of
the ensuing immune response. In this respect, the CD40-
CD154 partnership is thought to be a major factor in the
activation and function of DC, which can result in increased
interleukin 12 (IL-12) production with the potential to drive
Th1 polarization (5, 10, 16).
Chronic diseases caused by helminth infections, such as fi-
lariasis and schistosomiasis, are generally associated with
strong Th2-type responses (22). In keeping with this, the filar-
ial secretory product (ES-62) and the soluble fraction of schis-
tosome eggs clearly activate DC to drive the differentiation of
Th cell responses toward the Th2 pole (6, 19, 34). Both of these
helminth products are derived from parasite stages associated
with chronic or long-term exposure to the host. In contrast, it
is not known whether the initial and early infectious stages of
these parasites activate antigen-presenting cells (APCs), en-
abling them to drive polarized Th immune responses. In this
context, schistosome larvae in the skin site of exposure induce
a vigorous dermal inflammatory reaction and cellular influx
that includes DC and macrophages with putative APC func-
tions (11, 26, 28). In addition, there is evidence for the activa-
tion and maturation of DC in the skin, as determined by
up-regulation of MHC class II and CD86 expression (2, 11, 12,
28). However, it is not known what larval components are
responsible for activating these DC populations and how early
immune events affect the phenotype of the ensuing acquired
response.
In the absence of readily available quantities of immature
epidermally derived Langerhans cells and based upon the ac-
ceptance that all subsets of DC are functionally plastic, we
decided to use murine bone marrow-derived DC (BM-DC) to
investigate the ability to activate potential APCs from material
released by infectious schistosome cercariae within the first 3 h
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after transformation (0-3hRP). This was judged by cytokine
production, costimulatory molecule expression, and T-cell-po-
larizing function. We show that 0-3hRP activates DC, which
strongly drive Th cells toward the Th2 pole. However, ligation
of CD40 on DC activated by 0-3hRP instead favors differen-
tiation toward a more Th1-type response.
MATERIALS AND METHODS
Parasite material. Cercariae of Schistosoma mansoni were concentrated by
sedimentation on ice for 1 h and washed three times with sterile water. The
parasites were mechanically transformed by vortexing them for 90 s in RPMI
1640 containing 200 U of penicillin/ml and 100 g of streptomycin (Invitrogen,
Paisley, United Kingdom)/ml (RPMI-0) and cultured in vitro for 3 h at 37°C and
5% CO2. The culture supernatant was concentrated 50-fold using centrifugal
filter units (Ultrafree-MC with a 5-kDa cutoff; Millipore, Watford, United King-
dom); the preparation was designated 0-3hRP. As a control, an equivalent
volume of RPMI-0 containing no parasite material was concentrated as de-
scribed above (RPMIc). The preparations were sonicated (21kHz at 6.5-m
amplitude) for 3 min and centrifuged (100,000  g) for 1 h to yield the soluble
material. The protein content was determined using Coomasie Plus-200 (Perbio
Science UK Ltd., Tattenhall, United Kingdom), while the endotoxin concentra-
tion was determined using a Pyrogent Plus Limulus Amoebocyte Lysate test kit
(BioWhittaker, Wokingham, United Kingdom).
Animals and cell lines. All mice were maintained at the University of York.
BALB/c mice were obtained from Harlan UK Ltd. (Bicester, United Kingdom),
and DO11.10  TCR transgenic mice (on a BALB/c background) were a gift
from Paul Garside (University of Glasgow, Glasgow, United Kingdom). All
experiments were carried out in accordance with the guidelines of the United
Kingdom Animals (Scientific Procedures) Act 1986. The fibroblast cell lines
3T3-CD154 and 3T3-SAMEN (control) were gifts from P. Hwu (National Can-
cer Institute, Bethesda, Md.) and were derived from NIH 3T3 cells by stable
transfection with murine CD154 or empty vector, respectively.
Generation of DC from bone marrow. BM-DC were prepared using a method
adapted from that of Son et al. (31). Briefly, bone marrow cells were removed
from the femur and resuspended in RPMI 1640 containing 2 mM L-glutamine
(Invitrogen), 200 U of penicillin/ml, 100 g of streptomycin/ml, 50 M 2-mer-
captoethanol (Invitrogen), and 10% heat-inactivated low-endotoxin fetal calf
serum (Harlan Seralab, Loughborough, United Kingdom) (RPMI-10), and the
red blood cells were lysed with ammonium chloride buffer (0.15 M NH4Cl, 10
mM KHCO3, and 0.1 mM Na2EDTA). The bone marrow cells were then washed
three times with RPMI-10 before being cultured in six-well plates (Nalge Nunc
International Corp., Naperville, Ill.) at 1.8 106/well in 3 ml of RPMI-10 plus 20
ng of granulocyte-macrophage colony-stimulating factor (GM-CSF) (Peprotech,
London, United Kingdom)/ml. On day 4, a further 3 ml of RPMI-10 plus 40 ng
of GM-CSF/ml was added, and the cells were cultured for a further 2 days (i.e.,
to day 6). This protocol results in pluripotent DC that can elicit mixed Th
responses in the absence of added microbial stimuli and can drive Th1 or Th2
responses following maturation with different microbial agents.
DC stimulation and maturation. DC were seeded into 24- or 96-well plates
(Nalge Nunc) at 106/ml in RPMI-10 plus 20 ng of GM-CSF/ml. The cells were
cultured alone for 24 h or in the presence of 0-3hRP (40 g/ml), an equivalent
volume of RPMIc, LPS (1 or 100 ng/ml; from Escherichia coli strain 0111:B4;
Sigma-Aldrich, Poole, United Kingdom), or zymosan A (2 or 5 g/ml; from
Saccharomyces cerevisae; Sigma-Aldrich). In pilot experiments, the concentra-
tions of 0-3hRP were compared over 3 log units (0.05 to 100 g/ml), and 40
g/ml was found to be optimal in terms of the amount of cytokine produced
(unpublished observations). In order to control for low levels of naturally occur-
ring endotoxin in 0-3hRP (4.9  0.9 endotoxin units/40 g of protein), DC and
0-3hRP were cultured in the presence of polymyxin B (PMB; 3 g/ml; Sigma-
Aldrich). After culture with different stimuli, the mature DC were analyzed for
the expression of surface markers and intracellular IL-12p40, while the culture
supernatants were stored at 20°C prior to cytokine detection by enzyme-linked
immunosorbent assay (ELISA). As negative controls, DC were cultured with
PMB alone, with PMB plus RPMIc, or with PMB plus LPS (1 to 10 ng/ml)
containing a concentration of endotoxin equivalent to that of 0-3hRP. However,
no significant difference was observed in the cytokine production, or the expres-
sion of surface markers, by these control groups compared to DC-medium.
Therefore, only control data for DC-medium and/or DC-RPMIc are shown. In
some experiments, DC plus 0-3hRP and DC-medium were cultured either on a
monolayer of CD154 (or control) fibroblasts or in the presence of low-endo-
toxin anti-CD40 (CD40) monoclonal antibody (MAb) (5 g/ml; clone HM40-3;
BD PharMingen, Oxford, United Kingdom).
Phenotypic characterization of cell populations. Flow cytometric analysis of
various surface markers using specific MAbs or an irrelevant isotype-matched
MAb was performed as previously described (11, 12). The antibodies were
fluorescein isothiocyanate- or phycoerythrin-conjugated CD11c (HL3; BD
PharMingen), CD40 (3/23; BD PharMingen), CD80 (RMMP-1; Caltag-Medsys-
tems, Towcester, Ltd.), and CD86 (RMMP-2; Caltag) or biotin-conjugated I-Ab,d
(28-16-8S; Caltag) or OX40L (RM134L; BD PharMingen), followed by strepta-
vidin-conjugated Quantum Red (Sigma). Analysis was performed using a
Coulter Epics XL (Beckman Coulter, High Wycombe, United Kingdom).
In vitro T-cell-priming assay. In order to determine the T-cell-polarizing
function of differentially activated BM-DC, an antigen-restricted assay was used
incorporating CD4 T cells from DO11.10 transgenic mice, which express a
T-cell receptor (TCR) specific for OVA peptide (323-ISQAVHAAHAEINEA
GR-339) in complex with I-Ad MHC class II. CD4 cells were purified from
spleens of naı¨ve DO11.10 mice using magnetic-activated cell sorting; briefly,
splenocytes were incubated with CD4 microbeads for 15 min at 4°C, and
positive cells were selected by passage through a MACS MS column (Miltenyi
Biotec, Bisley, United Kingdom). Following overnight exposure to microbe-
derived stimuli, BM-DC were washed three times and irradiated (1,500 krads)
before being cultured in vitro (2.5  104 cells/ml) with CD4 splenocytes (2.5 
105/ml) in the presence or absence of OVA peptide (10 nM; Albachem, Univer-
sity of Edinburgh, United Kingdom). This dose of OVA has previously been
shown to permit DC to prime for both Th1 and Th2 responses (4, 34). A
DC/T-cell ratio of 1:10 was employed, since previous studies had demonstrated
that under these culture conditions, DC-media prime for a mixed Th response (4,
34). After 72 h, phorbol myristate acetate (50 ng/ml) and ionomycin (500 ng/ml;
Sigma-Aldrich) were added to the cells, and the culture supernatants were
harvested 24 h later.
In vivo T-cell-priming assay. For assays of in vivo T-cell priming, DC were
activated with different stimuli in the presence of OVA peptide (100 nM).
Culture of DC with OVA alone did not result in increased cytokine production,
confirming that the OVA was endotoxin free (data not shown). After being
thoroughly washed, differentially activated BM-DC (3  105 to 4.5  105 cells in
100 l) were delivered to recipient naı¨ve DO11.10 mice by subcutaneous injec-
tion over the sternum. After 7 days, single-cell suspensions from the skin-drain-
ing lymph nodes (sdLN) and spleens were prepared and cultured in 96-well
plates (sdLN cells, 2  105/well; splenocytes, 4  105/well) alone, with OVA
peptide (100 to 10,000 nM), or with plate-bound anti-CD3ε MAb (0.25 g/well;
clone 145-2C11; BD PharMingen). The cells were cultured in RPMI-0 supple-
mented with 2 mM L-glutamine, 50 M 2-mercaptoethanol, and 3% heat-inac-
tivated mouse serum, and 3 days later the culture supernatants were harvested.
Cytokine detection by ELISA. Culture supernatants were tested as appropriate
for the production of IL-1, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70, tumor
necrosis factor alpha, and gamma interferon (IFN-), using ELISA (11, 12).
IL-12p70 production was determined as for IL-12p40 but incorporated an IL-
12p70-specific capture antibody (clone 9A5; BD PharMingen).
Statistics. Comparisons of data within an individual experiment were tested
for significance using Student’s t test. Alternatively, data expressed as the mean
log increase (n-fold) in cytokine production from several experiments were
tested for difference from a theoretical value of 0 (equivalent to no increase or
decrease) using the one-sample Student t test. The following nomenclature was
used to indicate significant values: , P  0.05; , P  0.01; , P  0.001.
RESULTS
0-3hRP induces partial up-regulation of MHC class II and
costimulatory-molecule expression on DC. The ability of
0-3hRP to up-regulate the expression of MHC class II and
costimulatory molecules on BM-DC was tested compared to
the microbe-derived stimuli LPS and zymosan A, chosen for
their known ability to activate DC to prime for Th1- and
Th2-type responses, respectively (10, 19, 23, 34). DC were
cultured in medium alone (DC-medium) or exposed to 0-3hRP
(DC plus 0-3hRP), LPS (DC-LPS), zymosan A (DC-zymosan
A), or the concentrated medium RPMIc (DC-RPMIc) for 24 h
prior to analysis of the phenotype. The proportions of CD11c
DC plus 0-3hRP, DC-LPS, and DC-zymosan that expressed
high levels of MHC class II were all greater (P 	 0.05 to 0.01)
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than the negative controls (DC-medium and DC-RPMIc), al-
though fewer DC plus 0-3hRP were MHChi (70%) than DC-
LPS (76%) or DC-zymosan A (82%) (Fig. 1a). CD11c cells
within the DC population comprised 
95% of all MHC class
II events and were characterized by their large size and gran-
ularity (data not shown). Analysis of this DC population re-
vealed that 0-3hRP stimulated significant increases in the ex-
pression of CD40 and CD86hi (P 	 0.05), although LPS and
zymosan A stimulated greater up-regulation (Fig. 1b). Neither
CD80 nor OX40L expression was significantly upregulated by
activation with 0-3hRP, whereas LPS stimulated up-regulation
of CD80 (P 	 0.05), but not OX40L (P 
 0.05) and zymosan
A, stimulated up-regulation of OX40L (P 	 0.05), but not
CD80 (P 
 0.05) (Fig. 1b).
0-3hRP induces lower levels of cytokine production than
other microbial stimuli. 0-3hRP stimulated increased IL-
12p40 production (9-fold) than the two negative controls, al-
though this increase was lower than those stimulated by LPS
(96-fold) and zymosan A (99-fold) (Fig. 2a) (all P 	 0.001).
Consistent with this, the percentage of CD11c cells that were
IL-12p40 increased, and they had a higher intensity of cyto-
kine staining, as shown by flow cytometric analysis; DC plus
0-3hRP were 13% IL-12p40 with a mean fluorescence value
of 1.5 compared to DC-RPMIc (4.6%; 1.1), DC-LPS (58%;
4.8), and DC-zymosan (56%; 5.2) (data not shown). 0-3hRP
also stimulated an increase in IL-6 (28-fold), but both LPS
(218-fold) and zymosan A (75-fold) stimulated secretion of
greater amounts (Fig. 2b) (all P 	 0.001). Detectable quanti-
ties of IL-12p70 and IL-10 were secreted only in response to
LPS and zymosan A and not 0-3hRP (Fig. 2c and d).
0-3hRP instructs DC to prime for Th2 polarization in vitro.
An in vitro antigen-restricted assay was used to determine
whether DC plus 0-3hRP would prime for a distinct Th phe-
notype compared to DC-medium, DC-LPS, and DC-zymosan
A. In this assay, DC activated with the different stimuli were
cultured with CD4 splenocytes from DO11.10  TCR trans-
genic mice in the presence of their specific antigen (OVA
peptide), and the resulting profiles of Th1 (IFN-) and Th2
(IL-4) signature cytokines were determined. IFN- production
by CD4 cells, expressed as a log (n-fold) increase in cytokine
over that primed by DC-medium, was dramatically increased
following priming by DC-LPS (P 	 0.001), but not zymosan A
(Fig. 3). DC plus 0-3hRP appeared to prime for a slight in-
crease in IFN-, but this was not significant (P
 0.05) (Fig. 3).
In contrast, DC plus 0-3hRP primed CD4 cells to secrete
increased IL-4 (P 	 0.01), similar to that primed by DC-
zymosan A, whereas DC-LPS appeared to cause a decreased
log (n-fold) change in IL-4 (Fig. 3). Cultures of DC alone or
CD4 cells alone did not produce detectable levels of either
cytokine (data not shown).
DC activated with 0-3hRP drive T-helper cell differentiation
toward the Th2 pole. The ability of differentially activated DC
pulsed with OVA to prime Th cell responses in the sdLN of
DO11.10 mice was examined following their subcutaneous de-
livery. The location was employed to approximate events that
might follow percutaneous infection with schistosomes (11).
The outcome of in vivo T-cell priming was determined 7 days
after delivery of DC by restimulation of sdLN cells in vitro with
OVA peptide. Following inoculation with DC-LPS, sdLN cells
produced substantially more IFN- than cells from mice in-
jected with DC-medium (Fig. 4). This ranged from a two-fold
FIG. 1. 0-3hRP stimulates up-regulation of surface maturation
markers upon DC. The percentages of CD11c cells expressing MHC
class IIhi were determined in DC activated with medium only, RPMIc,
0-3hRP (40 g/ml), LPS (100 ng/ml), or zymosan A (2 g/ml) (a).
Alternatively, the percentage of large granular cells known to be
CD11c expressing CD40, CD80, CD86hi, or OX40L is shown (b).
Data are the mean plus standard error of the mean of three experi-
ments, and levels of significance are between DC-RPMIc and the DC
test groups.
FIG. 2. Cytokine production by DC following activation with
0-3hRP, LPS, and zymosan A. DC were cultured with medium only or
with different stimuli (as given in the legend to Fig. 1), and the pro-
duction of IL-12p40, IL-12p70, IL-6, and IL-10 was determined by
ELISA. Data are the mean plus standard error of the mean of four
individual wells and are representative of at least three experiments.
Levels of significance are between DC-RPMIc control and test groups.
The dotted line represents the lower limit of ELISA detection.
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increase, using 10,000 nM OVA, up to a five-fold increase
using only 100 nM OVA. Both DC plus 0-3hRP and DC-
zymosan A also primed for increased IFN- production by
sdLN cells (1.3- to 3-fold), but the levels were much lower than
those primed by DC-LPS. Analysis of Th2 cytokines revealed
that sdLN cells from recipients of DC plus 0-3hRP produced
dramatically increased levels of IL-4 (11- to 54-fold), IL-5 (5-
to 10-fold), and IL-10 (3- to 9-fold) compared to cells from
recipients of DC-medium (Fig. 4). In contrast, sdLN cells from
recipients of DC-LPS and DC-zymosan A did not secrete
abundant IL-4 or IL-10 (Fig. 4), although they both caused a
limited increase in IL-5 production (three- to five-fold) that
was much less than that primed by DC plus 0-3hRP (Fig. 4).
To determine if subcutaneous injection of differentially ma-
tured DC also results in polarized immune responses in other
sites, splenocytes from recipient mice were restimulated in
vitro as for sdLN cells. Splenocytes from mice injected with DC
plus 0-3hRP, DC-LPS, and DC-zymosan A all produced higher
levels of IFN- than cells from recipients of DC-medium, al-
though the greatest amounts were primed by DC-zymosan
and/or DC-LPS (Fig. 5). Analysis of Th2 cytokines demon-
strated that splenocytes from mice injected with DC plus
0-3hRP again produced dramatically increased levels of IL-4
compared to DC-medium and DC-LPS (Fig. 5). However, in
contrast to the situation in the sdLN, DC-zymosan A also
primed splenocytes for the production of high levels of IL-4.
Splenocytes from recipients of DC plus 0-3hRP and DC-zymo-
san A produced abundant levels of IL-5 and IL-10, whereas
cells from recipients of DC-medium and DC-LPS did not (Fig.
5). Splenocytes cultured with CD3 antibody (in place of
OVA) secreted profiles of cytokines that were comparable to
those of their OVA-restimulated counterparts (data not
shown).
These data sets clearly show that DC plus 0-3hRP drive both
local and systemic immune responses strongly toward the Th2
pole in vivo, while DC-LPS induce more Th1-type responses.
In contrast, DC-zymosan A consistently drive a nonpolarized
response in the sdLN but a Th2-type response in the spleen.
Ligation of CD40 on DC enhances cytokine production. The
effect of ligating CD40 upon the DC activation phenotype was
assessed by culturing cells with stimulatory CD40 MAb. The
presence of the CD40 MAb substantially increased IL-12p40
production by both DC-medium (10-fold) and DC plus 0-3hRP
(4-fold) but had little effect upon IL-6 production by DC-
FIG. 3. DC activated with 0-3hRP polarize naı¨ve CD4 cells to-
ward a Th2 phenotype in vitro. Differentially activated mDC (stimuli
as given in the legend to Fig. 1) were cocultured with CD4 cells from
DO11.10 mice in the presence of OVA peptide (10 nM). Culture
supernatants were analyzed by ELISA for IFN- and IL-4. Data are
the mean  standard error of the mean of the log increase (n-fold) in
cytokine production primed by test groups relative to DC-medium and
are derived from three experiments. The peaks of cytokine production
varied between experiments but were detected in the following ranges:
IFN-, 2,500 to 8,000 pg/ml, and IL-4, 800 to 1,600 pg/ml. Levels of
significance are between DC-medium and the DC test groups.
FIG. 4. DC activated with 0-3hRP drive polarization toward a Th2
phenotype in vivo. Naı¨ve DO11.10 mice were inoculated subcutane-
ously with differentially activated, OVA-pulsed DC (stimuli as given in
the legend to Fig. 1). After 7 days, sdLN cells were restimulated in
vitro with OVA (0 to 10,000 nM) for 72 h. Culture supernatants were
analyzed by ELISA for IFN-, IL-4, IL-5, and IL-10. Data are the
mean plus standard error of the mean of three individual wells and are
representative of four experiments. Levels of significance are between
DC-medium and the DC test groups. N.D., not done.
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medium (1.3-fold) or DC plus 0-3hRP (1.6-fold) (Fig. 6a). No
IL-12p70 or IL-10 was detected in any supernatants (data not
shown).
We also investigated the effect of CD40 ligation by cocul-
turing DC with a fibroblast cell line transfected to express
CD154. As expected, culture of DC-medium matured alone or
with control fibroblasts did not result in appreciable levels of
cytokine production, but the presence of CD154 fibroblasts
resulted in a dramatic increase in the production of IL-12p40,
IL-12p70, and IL-6 (Fig. 6b) (all P 	 0.001). DC plus 0-3hRP
matured alone or with control fibroblasts both released in-
creased levels of IL-12p40 and IL-6 compared to their DC-
medium counterparts. However, coculture of DC plus 0-3hRP
with CD154 fibroblasts also caused a dramatic increase in the
amounts of IL-12p40, IL-12p70, and IL-6 (all P 	 0.001) and
a slight increase in IL-10 (P 	 0.05) (Fig. 6b).
Culture of DC plus 0-3hRP with CD40 antibody impairs
their ability to drive Th2 responses. The in vivo method of
lymphocyte priming in DO11.10 TCR transgenic mice was
used to examine the effect of CD40 ligation upon the T-cell-
polarizing functions of DC-medium and DC plus 0-3hRP. For
this purpose CD40 MAb was used to ligate CD40 during
initial DC maturation. Upon restimulation with OVA in vitro,
sdLN cells from mice injected with CD40-treated DC-me-
dium and CD40-treated DC plus 0-3hRP produced more
IFN- than cells from mice injected with their respective un-
treated DC counterparts (Fig. 7). DC-medium treated with
CD40 MAb also primed sdLN cells to produce increased
levels of IL-4 and IL-5 relative to sdLN cells from mice in-
jected with untreated DC-medium (Fig. 7). However, although
very high levels of IL-4 and IL-5 were primed for by untreated
DC plus 0-3hRP, sdLN cells from recipients of CD40-treated
DC plus 0-3hRP produced significantly smaller quantities of
these Th2 cytokines (Fig. 7). Therefore, CD40 MAb treat-
FIG. 5. DC activated with 0-3hRP drive systemic Th2 polarization.
DO11.10 mice were inoculated subcutaneously with differentially ac-
tivated, OVA-pulsed DC (stimuli as given in the legend to Fig. 1).
After 7 days, splenocytes were restimulated in vitro with OVA (0 to
1,000 nM) for 72 h. Supernatants were analyzed by ELISA for IFN-,
IL-4, IL-5, and IL-10. Data are the mean plus standard error of the
mean of three individual wells and are representative of three exper-
iments. Levels of significance are between DC-medium and the DC
test groups.
FIG. 6. Ligation of CD40 increases IL-12 production by DC stim-
ulated with 0-3hRP. DC-medium or DC plus 0-3hRP were matured in
the presence or absence of CD40 MAb (5 g/ml) (a) or on a mono-
layer of CD154 or control fibroblasts (b). Culture supernatants were
tested by ELISA for IL-12p40, IL-12p70, IL-6, and IL-10; are shown as
the mean plus standard error of the mean of three or more wells; and
are representative of four experiments. Levels of significance are be-
tween untreated DC-medium or DC plus 0-3hRP and the respective
DCs cultured with CD154 fibroblasts or CD40 MAb. The dotted
line represents the lower limit of ELISA detection.
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ment of DC-medium increases their ability to prime in vivo for
both Th1 and Th2 cytokine production, whereas the same
treatment reverses the ability of DC plus 0-3hRP to prime for
Th2 responses, instead resulting in a more Th1-type profile of
cytokine production.
DISCUSSION
It is widely accepted that various types of microbe-derived
stimuli can differentially activate DC, resulting in contrasting
maturation phenotypes capable of driving polarized Th re-
sponses (4, 6, 19, 24, 30, 34). In this paper, we are the first to
report that material released by transforming schistosome lar-
vae (0-3hRP) activates BM-DC and instructs them to drive
acquired immune responses toward the Th2 pole both in vitro
and in vivo. In vitro priming of CD4 cells from DO11.10 TCR
transgenic mice with DC plus 0-3hRP resulted in the secretion
of IL-4 (but not IFN-) in quantities at least equal to that
primed by the Th2 inducer zymosan A. In contrast, DC acti-
vated with the classical Th1 inducer LPS (19, 33) promoted
greater levels of IFN-, but not IL-4. Furthermore, DC plus
0-3hRP also exhibited a strong Th2-driving function in vivo
following their adoptive transfer into naı¨ve DO11.10 mice. In
this respect, DC plus 0-3hRP primed for a substantial increase
in IL-4, IL-5, and IL-10 production by sdLN cells and spleno-
cytes compared to DC-medium and DC-LPS.
While the priming of Th cells in vitro by differentially acti-
vated DC in our study clearly leads to the development of
polarized Th1 and Th2 responses, it is evident that priming in
vivo also results in the limited up-regulation of cytokines char-
acteristic of the opposite pole. For example, DC plus 0-3hRP
and Th2-inducing DC-zymosan A stimulated limited IFN-
secretion in addition to abundant IL-4 and IL-5. Therefore,
differentially activated DC appear to prime for mixed, albeit
polarized, Th responses in vivo along a continuum between the
extreme Th1 and Th2 poles. The position of the immune re-
sponse along this continuum is likely to depend upon the
maturation status, or phenotype, of the DC population. In this
respect, the ability of DC plus 0-3hRP to prime toward the Th2
pole occurs in the absence of high-level cytokine production
and suboptimal levels of CD40 and CD86 expression. This
phenotype partially resembles the limited activation state of
DC stimulated with schistosome egg antigen and filarial ES-62
(19, 34). Consequently, our data on DC plus 0-3hRP support
the view that Th2 differentiation represents a T-cell default
pathway that occurs in the absence of both strong cytokine
production and costimulatory molecule expression (15, 19, 30,
34).
However, in contrast to the default hypothesis, our data also
show that DC-zymosan A “instruct ” for Th2 polarization,
despite producing abundant Th1-polarizing IL-12 (both bioac-
tive IL-12p70 and potentially inhibitory IL-12p40 ho-
modimers). This lends support to an alternative theory that
DC actively drive Th2 polarization, possibly through expres-
sion of specific factors (e.g., surface molecules, such as
Jagged1) (1). Nevertheless, our data do not allow the identifi-
cation of these factors. The greatest levels of IL-6 were made
by Th1-inducing DC-LPS, yet this cytokine has been associated
with the development of Th2-type responses (7, 8). In contrast,
abundant IL-12, which is known to drive Th1-type responses
(6), and IL-10, a cytokine thought to contribute to Th2 polar-
ization (23), were produced by both DC-LPS and Th2-inducing
DC-zymosan A. The role of costimulatory molecules in T-cell
polarization is also unclear. Although in our study only LPS
stimulated DC to up-regulate CD80 expression, supporting a
role in Th1 polarization (18), other studies suggest that the
expression of CD80 and CD86 on DC acts purely as a costimu-
latory rather than polarizing signal (34). On the other hand,
the interaction of OX40 with OX40L has been implicated in
Th2 polarization (6, 13), and we observed that OX40L was
up-regulated on DC-zymosan A. Nevertheless, OX40L was not
increased on DC plus 0-3hRP, calling into question its neces-
sity for the development of all Th2-type responses. Further-
more, our data do not support a role for low-density MHC
class II expression in Th2 polarization (29), since although DC
plus 0-3hRP stimulated the least up-regulation of MHC class
II, DC-zymosan A contained the greatest proportion of MHC
class IIhi cells. Although we have been unable to identify a
shared feature of DC plus 0-3hRP and DC-zymosan A that
explains their ability to induce Th2-type responses, an essential
Th2-driving factor common to both cannot be ruled out. How-
ever, it is likely that there are multiple mechanisms through
FIG. 7. Ligation of CD40 reverses the ability of DC activated with
0-3hRP to drive Th2 polarization. DO11.10 mice were inoculated
subcutaneously with OVA peptide-pulsed DC-medium or DC plus
0-3hRP in the presence or absence of CD40 MAb. After 7 days, sdLN
cells were restimulated in vitro with OVA peptide (0 to 1,000 nM) for
72 h. Culture supernatants were tested by ELISA for IFN-, IL-4, and
IL-5. Data are presented as the mean plus standard error of the mean
of three individual wells and are representative of two experiments.
Levels of significance are between DC-medium or DC plus 0-3hRP
cultured alone and the respective cultures treated with CD40 MAb.
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which DC prime for Th2-type responses that depend upon
their overall level of activation.
Despite zymosan A being described as a Th2-driving stimu-
lus (23), we found that in the sdLN DC-zymosan A failed to
prime a strong Th2-type response, although the production of
Th2-associated cytokines was evident in the spleen and follow-
ing in vitro priming. One explanation is that the kinetics of
immune priming induced by DC-zymosan A differs from that
induced by DC plus 0-3hRP, so that recall responses were no
longer detected in the sdLN 7 days postdelivery. Alternatively,
the lack of recall responsiveness in the sdLN may be evidence
for the induction of T-cell regulation. In this respect, zymosan
A is thought to signal through TLR-2, a receptor associated
with the instruction of DC to prime regulatory T-cell responses
(14, 33). Ultimately, our data suggest that DC plus 0-3hRP and
DC-zymosan A have overlapping yet unique phenotypes and
highlight the fact that the site of analysis of recall responses is
critical when assessing the outcome of T-cell priming by anti-
gen-pulsed DC in vivo.
One of the most critical factors in the activation of DC and
the priming and polarization of Th cells is the interaction of
CD40 with CD154. In addition to recording elevated expres-
sion of CD40 on DC after activation with 0-3hRP, we found
that ligation of CD40 on DC plus 0-3hRP (using either CD40
MAb or CD154 fibroblasts) led to a dramatic increase in the
production of IL-12 by DC. Treatment of DC plus 0-3hRP with
CD40 MAb caused them to prime Th cells in vivo to secrete
high levels of IFN-, thereby effectively reversing their ability
to prime for Th2 polarization. Similar effects were observed
following CD40 MAb treatment of DC-zymosan A (data not
shown). Ligation of CD40 following MAb treatment appears
to exert this pro-Th1 effect by preferentially increasing the
production of IL-12 (Fig. 6b) (5, 29). However, since the effect
of MAb treatment would likely mimic that of the T-cell–DC
interaction in vivo that results in a Th2 response, it is possible
that the CD40 MAb masks CD40, thus blocking signals re-
ceived by the T cell through CD154, which may be important
for Th2 development (20, 27). Either way, our data imply that
manipulation of the CD40-CD154 interaction favors the de-
velopment of Th1 responses at the expense of Th2 and under-
line the importance of signals received through CD40 on the
maturation status of activated DC.
Our observations have relevance for understanding how cer-
cariae first stimulate innate immune cells in the skin (including
Langerhans cells and dermal DC) following natural infection
and how these cells prime the acquired immune response. We
show that secretions from invading cercariae (i.e., 0-3hRP)
favor the activation of APCs that prime for Th2-type re-
sponses. Indeed, early responses (day 4) in the sdLN following
normal infection show evidence of transient Th2 cytokine pro-
duction in addition to Th1-associated IFN- (11), although
multiple exposures may further promote Th2 cytokine produc-
tion, as has been observed to occur following multiple expo-
sures to a related schistosome species, Trichobilharzia regentii
(17). In addition to possessing this instructional effect on
APCs, proteases contained within 0-3hRP directly stimulate
IL-4 production and histamine release by mast cells (21), sug-
gesting a general propensity to propagate Th2 responses. This
further supports a previous report (25) that 0-3hRP is less
prone to induce Th1-type responses in vitro than larval anti-
gens when used to restimulate sdLN cells taken from mice 4 to
6 days after larval exposure. The identity of the Th2-inducing
ligand(s) in 0-3hRP is not known, but it is a relatively hetero-
geneous mixture of molecules. A few DC-activating ligands of
helminth origin have been identified so far (see references 14,
22, and 30 for reviews), illustrating the diversity of molecular
structures which can stimulate DC to prime for Th2-type re-
sponses. One recently described product of schistosome eggs
that is a ligand of TLR2 is lyso-phosphatidylserine (33), but we
do not yet know if it is also present in 0-3hRP. Parasite-derived
prostaglandins are also a possible component of 0-3hRP and
may affect DC polarization (2, 14), but since these eicosanoids
are up-regulated by contact with fatty acids of skin origin and
our 0-3hRP was obtained without skin contact, we are of the
opinion that parasite-derived prostaglandins are unlikely to be
a significant factor in our experiments.
Finally, it is known that protective immunity induced by
radiation-attenuated S. mansoni larvae is associated with the
development of IL-12-dependent Th1-type responses initiated
in the skin (11, 12, 26). In this context, our observations that
ligation of CD40 on DC activated with 0-3hRP causes the
up-regulation of IL-12 production and the ability to prime for
Th1-type responses may provide a route by which we can favor
the development of protective Th1-associated immunity.
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